• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
37.3
71.68
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Carlyle to acquire 45% stake Edelweiss' home finance subsidiary
Feb 10,2026

Edelweiss Financial Services (Edelweiss) and global investment firm The Carlyle Group (NASDAQ: CG) today announced that investment funds affiliated with Carlyle will acquire a strategic majority stake in Nido Home Finance (Nido), a wholly-owned subsidiary of Edelweiss. As part of the transaction, investment funds affiliated with Carlyle Asia Partners (CAP) will invest Rs 2,100 crore (approximately USD 230M), which includes acquiring a 45% stake in Nido from Edelweiss through a secondary purchase and a primary equity capital infusion of Rs 1,500 crore  (approximately USD 165M) in Nido.